Jazz Pharmaceuticals (JAZZ) Gross Profit Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 411.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 7.16% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 4.34% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 51.16% |
| 10 | Jazz Pharmaceuticals | 14.64 Bn | 12.79 Bn | 934.80 Mn | 6.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.95% |
| Dec 31, 2025 | 9.08% |
| Sep 30, 2025 | 7.31% |
| Jun 30, 2025 | 4.75% |
| Mar 31, 2025 | 4.33% |
| Dec 31, 2024 | 8.05% |
| Sep 30, 2024 | 10.83% |
| Jun 30, 2024 | 13.05% |
| Mar 31, 2024 | 12.44% |
| Dec 31, 2023 | 13.71% |
| Sep 30, 2023 | 16.17% |
| Jun 30, 2023 | 17.49% |
| Mar 31, 2023 | 15.07% |
| Dec 31, 2022 | 13.78% |
| Sep 30, 2022 | 17.23% |
| Jun 30, 2022 | 17.72% |
| Mar 31, 2022 | 14.13% |
| Dec 31, 2021 | 19.11% |
| Sep 30, 2021 | 16.46% |
| Jun 30, 2021 | 11.09% |
| Mar 31, 2021 | 11.72% |
| Dec 31, 2020 | 14.39% |
| Sep 30, 2020 | 13.77% |
| Jun 30, 2020 | 13.67% |
| Mar 31, 2020 | 12.89% |
| Dec 31, 2019 | 14.61% |
| Sep 30, 2019 | 12.98% |
| Jun 30, 2019 | 11.76% |
| Mar 31, 2019 | 14.81% |
| Dec 31, 2018 | 12.42% |
| Sep 30, 2018 | 12.22% |
| Jun 30, 2018 | 14.14% |
| Mar 31, 2018 | 13.44% |
| Dec 31, 2017 | 11.16% |
| Sep 30, 2017 | 10.74% |
| Jun 30, 2017 | 11.79% |
| Mar 31, 2017 | 17.65% |
| Sep 30, 2016 | 18.99% |
| Jun 30, 2016 | 25.07% |
| Mar 31, 2016 | 22.86% |
| Dec 31, 2015 | 26.12% |
| Sep 30, 2015 | 29.93% |
| Jun 30, 2015 | 40.99% |
| Mar 31, 2015 | 43.82% |
| Dec 31, 2014 | 55.46% |
| Sep 30, 2014 | 59.54% |
| Jun 30, 2014 | 62.61% |
| Mar 31, 2014 | 64.52% |
| Sep 30, 2013 | 44.50% |
| Jun 30, 2013 | 44.56% |